Diagnostic Model for Proliferative HCC Using LI‐RADS : Assessing Therapeutic Outcomes in Hepatectomy and TKI‐ICI Combination
Journal of Magnetic Resonance Imaging · 2025
DOI: 10.1002/jmri.29400 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Magnetic Resonance Imaging, 2025. Verfasst von Mengtian Lu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Nantong University, Nantong, Jiangsu, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Hepatectomy, Magnetic Resonance Imaging. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Science and Technology Project of Nantong City, Nantong Municipal Commission of Health and Family Planning.
Abstract (Originalsprache)
Background
Proliferative hepatocellular carcinoma (HCC), aggressive with poor prognosis, and lacks reliable MRI diagnosis.
Purpose
To develop a diagnostic model for proliferative HCC using liver imaging reporting and data system (LI‐RADS) and assess its prognostic value. Study Type Retrospective. Population 241 HCC patients underwent hepatectomy (90 proliferative HCCs: 151 nonproliferative HCCs), divided into the training ( N = 167) and validation ( N = 74) sets. 57 HCC patients received combination therapy with tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs). Field Strength/Sequence 3.0 T, T1 ‐ and T2 ‐weighted, diffusion‐weighted, in‐ and out‐phase, T1 high resolution isotropic volume excitation and dynamic gadoxetic acid‐enhanced imaging. Assessment LI‐RADS v2018 and other MRI features (intratumoral artery, substantial hypoenhancing component, hepatobiliary phase peritumoral hypointensity, and irregular tumor margin) were assessed. A diagnostic model for proliferative HCC was established, stratifying patients into high‐ and low‐risk groups. Follow‐up occurred every 3–6 months, and recurrence‐free survival (RFS), progression‐free survival (PFS) and overall survival (OS) in different groups were compared. Statistical Tests Fisher's test or chi‐square test, t ‐test or Mann–Whitney test, logistic regression, Harrell's concordance index (C‐index), Kaplan–Meier curves, and Cox proportional hazards. Significance level: P < 0.05.
Results
The diagnostic model, incorporating corona enhancement, rim arterial phase hyperenhancement, infiltrative appearance, intratumoral artery, and substantial hypoenhancing component, achieved a C‐index of 0.823 (training set) and 0.804 (validation set). Median follow‐up was 32.5 months (interquartile range [IQR], 25.1 months) for postsurgery patients, and 16.8 months (IQR: 13.2 months) for combination‐treated patients. 99 patients experienced recurrence, and 30 demonstrated tumor nonresponse. Differences were significant in RFS and OS rates between high‐risk and low‐risk groups post‐surgery (40.3% vs. 65.8%, 62.3% vs. 90.1%, at 5 years). In combination‐treated patients, PFS rates differed significantly (80.6% vs. 7.7% at 2 years). Data Conclusion The MR‐based model could pre‐treatment identify proliferative HCC and assist in prognosis evaluation. Level of Evidence 4. Technical Efficacy Stage 2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nantong University, Nantong, Jiangsu, China.
- Department of Radiology, Affiliated Nantong Hospital 3 of Nantong University, Nantong Third People's Hospital, Nantong, Jiangsu, China.
- Department of Hepatobiliary Surgery, Affiliated Nantong Hospital 3 of Nantong University, Nantong Third People's Hospital, Nantong, Jiangsu, China.
- Department of Pathology, Affiliated Nantong Hospital 3 of Nantong University, Nantong Third People's Hospital, Nantong, Jiangsu, China.
ORCID-Profile: Tao Zhang, Xueqin Zhang
Förderung
- Science and Technology Project of Nantong City
- Nantong Municipal Commission of Health and Family Planning
Zitieren
APA
Lu, M., Yan, Z., Qu, Q., Zhu, G., Xu, L., Liu, M., Jiang, J., Gu, C., Chen, Y., Zhang, T., & Zhang, X. (2025). Diagnostic Model for Proliferative HCC Using LI‐RADS : Assessing Therapeutic Outcomes in Hepatectomy and TKI‐ICI Combination. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.29400
Vancouver
Lu M, Yan Z, Qu Q, Zhu G, Xu L, Liu M, et al. Diagnostic Model for Proliferative HCC Using LI‐RADS : Assessing Therapeutic Outcomes in Hepatectomy and TKI‐ICI Combination. Journal of Magnetic Resonance Imaging. 2025. doi:10.1002/jmri.29400
BibTeX
@article{Lu2025,
author = {Lu, Mengtian and Yan, Zuyi and Qu, Qi and Zhu, Guodong and Xu, Lei and Liu, Maotong and Jiang, Jifeng and Gu, Chunyan and Chen, Ying and Zhang, Tao and Zhang, Xueqin},
title = {Diagnostic Model for Proliferative HCC Using LI‐RADS : Assessing Therapeutic Outcomes in Hepatectomy and TKI‐ICI Combination},
journal = {Journal of Magnetic Resonance Imaging},
year = {2025},
doi = {10.1002/jmri.29400}
}
EUVIMED